Among these apoptotic regulators, it is worth mentioning that the gene expression of BCL2, an antiapoptotic protein overexpressed in CLL associated to leukemia cell survival and therapy resistance (40), was significantly downregulated in primary CLL cells after treatment with EC-7072 (Supplementary Figure 7A). Here, BCL2 is linked to leukemia.